UNASSIGNED: Patients who underwent ACL reconstruction were allocated to two groups (HT and PLT). Graft diameter was measured intraoperatively. Knee functional outcome was evaluated with IKDC and Tegner-Lysholm scores preoperatively, and postoperatively after 3 months, 6 months, and 1 year. Donor site morbidities were assessed with thigh circumference measurements, subjective evaluation of sensory disturbances, and ankle scoring with AOFAS and FADI scores.
UNASSIGNED: At 1-year follow-up, the PLT group showed comparable IKDC (p = 0.925) and Tegner-Lysholm (p = 0.600) scores with those of the HT group. The mean graft diameter in the PLT group (7.93 ± 0.52 mm) was larger compared with the HT group (7.43 ± 0.50 mm) (p < 0.001). The incidence of thigh atrophy (HT-16.7%, PLT-10%) and sensory disturbances (HT-73.3%, PLT-10%) was greater in the HT group. There was no significant ankle donor site morbidity in the PLT group (AOFAS-98.67 ± 3.45, FADI-99.23 ± 1.69).
UNASSIGNED: ACL reconstruction with PLT had comparable functional outcome with that of HT at 1 year. However, PLT demonstrated larger graft diameter, less donor site morbidity, and enhanced muscle recovery without significantly affecting the ankle function. PLT can be safely used as an acceptable alternative graft choice harvested from outside the knee for ACL reconstruction.
■将接受ACL重建的患者分为两组(HT和PLT)。术中测量移植物直径。术前使用IKDC和Tegner-Lysholm评分评估膝关节功能结局,术后3个月,6个月,和1年。通过大腿围测量来评估供体部位的发病率。感觉障碍的主观评价,和脚踝得分与AOFAS和FADI得分。
■在1年的随访中,PLT组的IKDC(p=0.925)和Tegner-Lysholm(p=0.600)评分与HT组相当.PLT组的平均移植物直径(7.93±0.52mm)大于HT组(7.43±0.50mm)(p<0.001)。大腿萎缩的发生率(HT-16.7%,PLT-10%)和感觉障碍(HT-73.3%,HT组PLT-10%)更大。PLT组无明显踝关节供体部位发病率(AOFAS-98.67±3.45,FADI-99.23±1.69)。
■用PLT重建ACL在1年时具有与HT相当的功能结果。然而,PLT显示较大的移植物直径,供体部位发病率较低,增强肌肉恢复而不显著影响踝关节功能。PLT可以安全地用作从膝关节外收获的可接受的替代移植物选择,用于ACL重建。